This page in English

Karin Ekström Smedby

Forskare

Besöksadress : Eugeniahemmet, T2, Karolinska Universitetssjukhuset, Solna 171 76 Stockholm
Postadress : Institutionen för medicin, Solna (MedS), K2, Forskargrupp K Ekström Smedby, Eugeniahemmet, T2, Karolinska Universitetssjukhuset, Solna 171 76 Stockholm
Leveransadress : Eugeniahemmet, T2, Karolinska Universitetssjukhuset, Solna 171 76 Stockholm

Utbildning

Docent 2010, Karolinska Institutet

PhD 2005, Karolinska institutet

Läkarexamen, Uppsala universitet

Forskningsbeskrivning

Utvalda publikationer

Possible Interaction Between Cigarette Smoking and HLA-DRB1 Variation in the Risk of Follicular Lymphoma.
Baecklund F, Foo J, Askling J, Eloranta S, Glimelius I, Liu J, et al
Am. J. Epidemiol. 2017 04;185(8):681-687

Increased healthcare use up to 10 years among relapse-free Hodgkin lymphoma survivors in the era of intensified chemotherapy and limited radiotherapy.
Glimelius I, Eloranta S, Ekberg S, Chang E, Neovius M, Smedby K
Am. J. Hematol. 2017 Mar;92(3):251-258

["Tools for clinical research"--a new series of articles in Läkartidningen].
Smedby K, Lagerros Y
Lakartidningen ;110(3):81

Pregnancy and the Risk of Relapse in Patients Diagnosed With Hodgkin Lymphoma.
Weibull C, Eloranta S, Smedby K, Björkholm M, Kristinsson S, Johansson A, et al
J. Clin. Oncol. 2016 Feb;34(4):337-44

Risk of disability pension in patients following rectal cancer treatment and surgery.
Chen L, Glimelius I, Neovius M, Eloranta S, Ekberg S, Martling A, et al
Br J Surg 2015 Oct;102(11):1426-32

Patients with ulcerative colitis miss more days of work than the general population, even following colectomy.
Neovius M, Arkema E, Blomqvist P, Ekbom A, Smedby K
Gastroenterology 2013 Mar;144(3):536-43

Lifestyle factors, autoimmune disease and family history in prognosis of non-hodgkin lymphoma overall and subtypes.
Simard J, Baecklund F, Chang E, Baecklund E, Hjalgrim H, -Olov Adami H, et al
Int. J. Cancer 2013 Jun;132(11):2659-66

A meta-analysis of genome-wide association studies of follicular lymphoma.
Skibola C, Conde L, Foo J, Riby J, Humphreys K, Sillé F, et al
BMC Genomics 2012 Oct;13():516

Risk of skin cancer and other malignancies in kidney, liver, heart and lung transplant recipients 1970 to 2008--a Swedish population-based study.
Krynitz B, Edgren G, Lindelöf B, Baecklund E, Brattström C, Wilczek H, et al
Int. J. Cancer 2013 Mar;132(6):1429-38

Coding variants at hexa-allelic amino acid 13 of HLA-DRB1 explain independent SNP associations with follicular lymphoma risk.
Foo J, Smedby K, Akers N, Berglund M, Irwan I, Jia X, et al
Am. J. Hum. Genet. 2013 Jul;93(1):167-72

Incidence and time trends of brain metastases admissions among breast cancer patients in Sweden.
Frisk G, Svensson T, Bäcklund L, Lidbrink E, Blomqvist P, Smedby K
Br. J. Cancer 2012 May;106(11):1850-3

GWAS of follicular lymphoma reveals allelic heterogeneity at 6p21.32 and suggests shared genetic susceptibility with diffuse large B-cell lymphoma.
Smedby K, Foo J, Skibola C, Darabi H, Conde L, Hjalgrim H, et al
PLoS Genet. 2011 Apr;7(4):e1001378

Pediatric organ transplantation and risk of premalignant and malignant tumors in Sweden.
Simard J, Baecklund E, Kinch A, Brattström C, Ingvar A, Molin D, et al
Am. J. Transplant. 2011 Jan;11(1):146-51

Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32.
Conde L, Halperin E, Akers N, Brown K, Smedby K, Rothman N, et al
Nat. Genet. 2010 Aug;42(8):661-4

Borrelia infection and risk of non-Hodgkin lymphoma.
Schöllkopf C, Melbye M, Munksgaard L, Smedby K, Rostgaard K, Glimelius B, et al
Blood 2008 Jun;111(12):5524-9

Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium.
Ekström Smedby K, Vajdic C, Falster M, Engels E, Martínez-Maza O, Turner J, et al
Blood 2008 Apr;111(8):4029-38

Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype.
Smedby K, Hjalgrim H, Askling J, Chang E, Gregersen H, Porwit-MacDonald A, et al
J. Natl. Cancer Inst. 2006 Jan;98(1):51-60

Ultraviolet radiation exposure and risk of malignant lymphomas.
Smedby K, Hjalgrim H, Melbye M, Torrång A, Rostgaard K, Munksgaard L, et al
J. Natl. Cancer Inst. 2005 Feb;97(3):199-209

 

 

Pedagogiska meriter

Studierektor forskarskolan för kliniker i epidemiologi 2007-2009

Publikationer

EGR2 mutations define a new clinically aggressive subgroup of chronic lymphocytic leukemia
Young E, Noerenberg D, Mansouri L, Ljungström V, Frick M, Sutton La, et al
Leukemia 2017;31(7):1547-1554

Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia
Law Pj, Berndt Si, Speedy He, Camp Nj, Sava Gp, Skibola Cf, et al
Nature communications 2017;8():14175-

Increased healthcare use up to 10 years among relapse-free Hodgkin lymphoma survivors in the era of intensified chemotherapy and limited radiotherapy
Glimelius I, Eloranta S, Ekberg S, Chang Et, Neovius M, Smedby Ke
American journal of hematology 2017;92(3):251-258

Maternal Cancer During Pregnancy and Risks of Stillbirth and Infant Mortality
Lu D, Ludvigsson Jf, Smedby Ke, Fall K, Valdimarsdóttir U, Cnattingius S, et al
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2017;35(14):1522-1529

Patterns of acute inflammatory symptoms prior to cancer diagnosis
Setiawan A, Yin L, Auer G, Czene K, Smedby Ke, Pawitan Y
Scientific reports 2017;7(1):67-

Prevalence of paediatric inflammatory bowel disease in Sweden: a nationwide population-based register study
Ludvigsson Jf, Büsch K, Olén O, Askling J, Smedby Ke, Ekbom A, et al
BMC gastroenterology 2017;17(1):23-

Rheumatoid Arthritis and Risk of Malignant Lymphoma: Is the Risk Still Increased?
Hellgren K, Baecklund E, Backlin C, Sundstrom C, Smedby Ke, Askling J
Arthritis & rheumatology (Hoboken, N.J.) 2017;69(4):700-708

Risk of second primary cancer in patients treated with radiotherapy for rectal cancer
Martling A, Smedby Ke, Birgisson H, Olsson H, Granath F, Ekbom A, et al
The British journal of surgery 2017;104(3):278-287

Treatment Restarting After Discontinuation of Adjuvant Hormone Therapy in Breast Cancer Patients
He W, Smedby Ke, Fang F, Olsson H, Margolin S, Hall P, et al
Journal of the National Cancer Institute 2017;109(10):-

15-year follow-up of the Second Nordic Mantle Cell Lymphoma trial (MCL2): prolonged remissions without survival plateau
Eskelund Cw, Kolstad A, Jerkeman M, Räty R, Laurell A, Eloranta S, et al
British journal of haematology 2016;175(3):410-418

Association Between Long-term Oral Contraceptive Use and Risk of Crohn's Disease Complications in a Nationwide Study
Khalili H, Granath F, Smedby Ke, Ekbom A, Neovius M, Chan At, et al
Gastroenterology 2016;150(7):1561-1567.e1

ATM mutations in major stereotyped subsets of chronic lymphocytic leukemia: enrichment in subset #2 is associated with markedly short telomeres
Navrkalova V, Young E, Baliakas P, Radova L, Sutton La, Plevova K, et al
Haematologica 2016;101(9):e369-73

Chemotherapeutic intensity and survival differences in young patients with diffuse large B-cell lymphoma: a Swedish Lymphoma Registry study
Melén Cm, Enblad G, Sonnevi K, Junlén Hr, Smedby Ke, Jerkeman M, et al
British journal of haematology 2016;175(4):614-622

Genetically predicted longer telomere length is associated with increased risk of B-cell lymphoma subtypes
Machiela Mj, Lan Q, Slager Sl, Vermeulen Rc, Teras Lr, Camp Nj, et al
Human molecular genetics 2016;25(8):1663-76

Lost workdays in uterine cervical cancer survivors compared to the general population: impact of treatment and relapse
Everhov Åh, Ekberg S, Hirschberg Al, Bergmark K, Rådestad Af, Glimelius I, et al
Journal of cancer survivorship : research and practice 2016;10(3):514-23

Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia
Berndt Si, Camp Nj, Skibola Cf, Vijai J, Wang Z, Gu J, et al
Nature communications 2016;7():10933-

Meta-analysis of genome-wide association studies reveals genetic overlap between Hodgkin lymphoma and multiple sclerosis
Khankhanian P, Cozen W, Himmelstein Ds, Madireddy L, Din L, Van Den Berg A, et al
International journal of epidemiology 2016;45(3):728-40

Pregnancy and the Risk of Relapse in Patients Diagnosed With Hodgkin Lymphoma
Weibull Ce, Eloranta S, Smedby Ke, Björkholm M, Kristinsson Sy, Johansson Al, et al
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2016;34(4):337-44

Prognostic impact of epigenetic classification in chronic lymphocytic leukemia: The case of subset #2
Bhoi S, Ljungström V, Baliakas P, Mattsson M, Smedby Ke, Juliusson G, et al
Epigenetics 2016;11(6):449-55

Risk of basal cell carcinoma in Swedish organ transplant recipients: a population-based study
Krynitz B, Olsson H, Lundh Rozell B, Lindelöf B, Edgren G, Smedby Ke
The British journal of dermatology 2016;174(1):95-103

Risk of lymphoid neoplasms in a Swedish population-based cohort of 337,437 patients undergoing appendectomy
Mohammadi M, Song H, Cao Y, Glimelius I, Ekbom A, Ye W, et al
Scandinavian journal of gastroenterology 2016;51(5):583-9

Serum Androgen Levels and Sexual Function Before and One Year After Treatment of Uterine Cervical Cancer: A Pilot Study
Everhov Åh, Flöter Rådestad A, Nyberg T, Smedby Ke, Bergmark K, Lindén Hirschberg A
The journal of sexual medicine 2016;13(3):413-24

UGT2B17 expression: a novel prognostic marker within IGHV-mutated chronic lymphocytic leukemia?
Bhoi S, Baliakas P, Cortese D, Mattsson M, Engvall M, Smedby Ke, et al
Haematologica 2016;101(2):e63-5

Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations
Ljungström V, Cortese D, Young E, Pandzic T, Mansouri L, Plevova K, et al
Blood 2016;127(8):1007-16

Work Loss Duration and Predictors Following Rectal Cancer Treatment among Patients with and without Prediagnostic Work Loss
Chen L, Glimelius I, Neovius M, Ekberg S, Martling A, Eloranta S, et al
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2016;25(6):987-94

A genome-wide association study of marginal zone lymphoma shows association to the HLA region
Vijai J, Wang Z, Berndt Si, Skibola Cf, Slager Sl, De Sanjose S, et al
Nature communications 2015;6():5751-

Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for Thirteen Cancer Types
Sampson Jn, Wheeler Wa, Yeager M, Panagiotou O, Wang Z, Berndt Si, et al
Journal of the National Cancer Institute 2015;107(12):djv279-

A Novel Risk Locus at 6p21.3 for Epstein-Barr Virus-Positive Hodgkin Lymphoma
Delahaye-sourdeix M, Urayama Ky, Gaborieau V, Veenstra R, Foll M, Chabrier A, et al
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2015;24(12):1838-43

Associations of Non-Hodgkin Lymphoma (NHL) Risk With Autoimmune Conditions According to Putative NHL Loci
Wang Ss, Vajdic Cm, Linet Ms, Slager Sl, Voutsinas J, Nieters A, et al
AMERICAN JOURNAL OF EPIDEMIOLOGY 2015;181(6):406-21

Autoimmune and Atopic Disorders and Risk of Classical Hodgkin Lymphoma
Hollander P, Rostgaard K, Smedby Ke, Chang Et, Amini Rm, Brown Pd, et al
AMERICAN JOURNAL OF EPIDEMIOLOGY 2015;182(7):624-32

Common variation at 12q24.13 (OAS3) influences chronic lymphocytic leukemia risk
Sava Gp, Speedy He, Di Bernardo Mc, Dyer Mj, Holroyd A, Sunter Nj, et al
Leukemia 2015;29(3):748-51

Cutaneous malignant melanoma in the Swedish organ transplantation cohort: A study of clinicopathological characteristics and mortality
Krynitz B, Rozell Bl, Lyth J, Smedby Ke, Lindelöf B
Journal of the American Academy of Dermatology 2015;73(1):106-113.e2

Distinct effects of anti-inflammatory and anti-thrombotic drugs on cancer characteristics at diagnosis
Pawitan Y, Yin L, Setiawan A, Auer G, Smedby Ke, Czene K
European journal of cancer (Oxford, England : 1990) 2015;51(6):751-7

Erratum to: Sick leave and disability pension in Hodgkin lymphoma survivors by stage, treatment, and follow-up time-a population-based comparative study
Glimelius I, Ekberg S, Linderoth J, Jerkeman M, Chang Et, Neovius M, et al
Journal of cancer survivorship : research and practice 2015;9(4):610-1

Functional loss of IκBε leads to NF-κB deregulation in aggressive chronic lymphocytic leukemia
Mansouri L, Sutton La, Ljungström V, Bondza S, Arngården L, Bhoi S, et al
The Journal of experimental medicine 2015;212(6):833-43

Hormone therapy after uterine cervical cancer treatment: a Swedish population-based study
Everhov Åh, Nyberg T, Bergmark K, Citarella A, Rådestad Af, Hirschberg Al, et al
Menopause (New York, N.Y.) 2015;22(6):633-9

Leukemia and myelodysplastic syndrome in granulomatosis with polyangiitis: subtypes, clinical characteristics, and outcome
Knight A, Hjorton K, Sundström C, Höglund M, Backlin C, Smedby Ke, et al
The Journal of rheumatology 2015;42(4):690-4

Long-term survival in young and middle-aged Hodgkin lymphoma patients in Sweden 1992-2009-trends in cure proportions by clinical characteristics
Glimelius I, Ekberg S, Jerkeman M, Chang Et, Björkholm M, Andersson Tm, et al
American journal of hematology 2015;90(12):1128-34

Maternal and birth anthropometric characteristics in relation to the risk of childhood lymphomas: a Swedish nationwide cohort study
Petridou Et, Sergentanis Tn, Skalkidou A, Antonopoulos Cn, Dessypris N, Svensson T, et al
European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2015;24(6):535-41

Non-Hodgkin Lymphoma, Body Mass Index, and Cytokine Polymorphisms: A Pooled Analysis from the InterLymph Consortium
Kane E, Skibola Cf, Bracci Pm, Cerhan Jr, Costas L, Smedby Ke, et al
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2015;24(7):1061-70

Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations
Baliakas P, Agathangelidis A, Hadzidimitriou A, Sutton La, Minga E, Tsanousa A, et al
Blood 2015;125(5):856-9

Probability, rate and timing of reconstructive surgery following colectomy for inflammatory bowel disease in Sweden: a population-based cohort study
Nordenvall C, Myrelid P, Ekbom A, Bottai M, Smedby Ke, Olén O, et al
Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland 2015;17(10):882-90

Recurrent mutations refine prognosis in chronic lymphocytic leukemia
Baliakas P, Hadzidimitriou A, Sutton La, Rossi D, Minga E, Villamor N, et al
Leukemia 2015;29(2):329-36

Risk of disability pension in patients following rectal cancer treatment and surgery
Chen L, Glimelius I, Neovius M, Eloranta S, Ekberg S, Martling A, et al
The British journal of surgery 2015;102(11):1426-32

Sick leave and disability pension among Swedish testicular cancer survivors according to clinical stage and treatment
Nord C, Olofsson Se, Glimelius I, Cedermark Gc, Ekberg S, Cavallin-ståhl E, et al
Acta oncologica (Stockholm, Sweden) 2015;54(10):1770-80

Sick leave and disability pension in Hodgkin lymphoma survivors by stage, treatment, and follow-up time--a population-based comparative study
Glimelius I, Ekberg S, Linderoth J, Jerkeman M, Chang Et, Neovius M, et al
Journal of cancer survivorship : research and practice 2015;9(4):599-609

The impact of comorbid disease history on all-cause and cancer-specific mortality in myeloid leukemia and myeloma - a Swedish population-based study
Mohammadi M, Cao Y, Glimelius I, Bottai M, Eloranta S, Smedby Ke
BMC cancer 2015;15():850-

Time trends in incidence of cutaneous melanoma by detailed anatomical location and patterns of ultraviolet radiation exposure: a retrospective population-based study
Gordon D, Gillgren P, Eloranta S, Olsson H, Gordon M, Hansson J, et al
Melanoma research 2015;25(4):348-56

A comprehensive evaluation of the role of genetic variation in follicular lymphoma survival
Baecklund F, Foo Jn, Bracci P, Darabi H, Karlsson R, Hjalgrim H, et al
BMC medical genetics 2014;15():113-

A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia
Speedy He, Di Bernardo Mc, Sava Gp, Dyer Mj, Holroyd A, Wang Y, et al
Nature genetics 2014;46(1):56-60

A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus
Cozen W, Timofeeva Mn, Li D, Diepstra A, Hazelett D, Delahaye-sourdeix M, et al
Nature communications 2014;5():3856-

Ankylosing spondylitis, psoriatic arthritis, and risk of malignant lymphoma: a cohort study based on nationwide prospectively recorded data from Sweden
Hellgren K, Smedby Ke, Backlin C, Sundstrom C, Feltelius N, Eriksson Jk, et al
Arthritis & rheumatology (Hoboken, N.J.) 2014;66(5):1282-90

Anti-Müllerian hormone in premenopausal women following treatment of uterine cervical cancer
Hallqvist Everhov A, Bergmark K, Smedby Ke, Lindén Hirschberg A, Flöter Rådestad A
Acta obstetricia et gynecologica Scandinavica 2014;93(9):949-53

Aspirin intake and breast cancer survival - a nation-wide study using prospectively recorded data in Sweden
Holmes Md, Olsson H, Pawitan Y, Holm J, Lundholm C, Andersson Tm, et al
BMC cancer 2014;14():391-

Cancer survivorship and work loss--what are the risks and determinants?
Smedby Ke
Acta oncologica (Stockholm, Sweden) 2014;53(6):721-3

Clinical effect of stereotyped B-cell receptor immunoglobulins in chronic lymphocytic leukaemia: a retrospective multicentre study
Baliakas P, Hadzidimitriou A, Sutton La, Minga E, Agathangelidis A, Nichelatti M, et al
LANCET HAEMATOLOGY 2014;1(2):E74-E84

Clinical effect of stereotyped B-cell receptor immunoglobulins in chronic lymphocytic leukaemia: a retrospective multicentre study
Baliakas P, Hadzidimitriou A, Sutton La, Minga E, Agathangelidis A, Nichelatti M, et al
The Lancet. Haematology 2014;1(2):e74-84

Etiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph Non-Hodgkin Lymphoma Subtypes Project
Morton Lm, Slager Sl, Cerhan Jr, Wang Ss, Vajdic Cm, Skibola Cf, et al
Journal of the National Cancer Institute. Monographs 2014;2014(48):130-44

Feasibility of targeted next-generation sequencing of the TP53 and ATM genes in chronic lymphocytic leukemia
Mansouri L, Sutton La, Ljungström V, Sörqvist Ef, Gunnarsson R, Smedby Ke, et al
Leukemia 2014;28(3):694-6

Genome-wide association study identifies five susceptibility loci for follicular lymphoma outside the HLA region
Skibola Cf, Berndt Si, Vijai J, Conde L, Wang Z, Yeager M, et al
American journal of human genetics 2014;95(4):462-71

Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma
Cerhan Jr, Berndt Si, Vijai J, Ghesquières H, Mckay J, Wang Ss, et al
Nature genetics 2014;46(11):1233-8

High prevalence of human cytomegalovirus in brain metastases of patients with primary breast and colorectal cancers
Taher C, Frisk G, Fuentes S, Religa P, Costa H, Assinger A, et al
Translational oncology 2014;7(6):732-40

Identification of B-cell lymphoma subsets by plasma protein profiling using recombinant antibody microarrays
Pauly F, Smedby Ke, Jerkeman M, Hjalgrim H, Ohlsson M, Rosenquist R, et al
Leukemia research 2014;38(6):682-90

Lymphoma development in patients with autoimmune and inflammatory disorders--what are the driving forces?
Baecklund E, Smedby Ke, Sutton La, Askling J, Rosenquist R
Seminars in cancer biology 2014;24():61-70

Medical history, lifestyle, family history, and occupational risk factors for mantle cell lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project
Smedby Ke, Sampson Jn, Turner Jj, Slager Sl, Maynadié M, Roman E, et al
Journal of the National Cancer Institute. Monographs 2014;2014(48):76-86

Medical history, lifestyle, family history, and occupational risk factors for marginal zone lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project
Bracci Pm, Benavente Y, Turner Jj, Paltiel O, Slager Sl, Vajdic Cm, et al
Journal of the National Cancer Institute. Monographs 2014;2014(48):52-65

Mortality after total colectomy in 3084 patients with inflammatory bowel disease: a population-based cohort study
Nordenvall C, Ekbom A, Bottai M, Smedby Ke, Nilsson Pj
Alimentary pharmacology & therapeutics 2014;40(3):280-7

Nationwide prevalence of inflammatory bowel disease in Sweden: a population-based register study
Büsch K, Ludvigsson Jf, Ekström-smedby K, Ekbom A, Askling J, Neovius M
Alimentary pharmacology & therapeutics 2014;39(1):57-68

On the way towards a 'CLL prognostic index': focus on TP53, BIRC3, SF3B1, NOTCH1 and MYD88 in a population-based cohort
Cortese D, Sutton La, Cahill N, Smedby Ke, Geisler C, Gunnarsson R, et al
Leukemia 2014;28(3):710-3

Rationale and Design of the International Lymphoma Epidemiology Consortium (InterLymph) Non-Hodgkin Lymphoma Subtypes Project
Morton Lm, Sampson Jn, Cerhan Jr, Turner Jj, Vajdic Cm, Wang Ss, et al
Journal of the National Cancer Institute. Monographs 2014;2014(48):1-14

Risk and predictors of attempted and completed suicide in patients with hematological malignancies
Mohammadi M, Moradi T, Bottai M, Reutfors J, Cao Y, Smedby Ke
Psycho-oncology 2014;23(11):1276-82

Sentinel node location in trunk and extremity melanomas: uncommon or multiple lymph drainage does not affect survival
Gordon D, Smedby Ke, Schultz I, Olsson H, Ingvar C, Hansson J, et al
Annals of surgical oncology 2014;21(11):3386-94

450K-array analysis of chronic lymphocytic leukemia cells reveals global DNA methylation to be relatively stable over time and similar in resting and proliferative compartments
Cahill N, Bergh Ac, Kanduri M, Göransson-kultima H, Mansouri L, Isaksson A, et al
Leukemia 2013;27(1):150-8

Cigarette smoking and risk of Hodgkin lymphoma and its subtypes: a pooled analysis from the International Lymphoma Epidemiology Consortium (InterLymph)
Kamper-jorgensen M, Rostgaard K, Glaser Sl, Zahm Sh, Cozen W, Smedby Ke, et al
ANNALS OF ONCOLOGY 2013;24(9):2245-55

Coding Variants at Hexa-allelic Amino Acid 13 of HLA-DRB1 Explain Independent SNP Associations with Follicular Lymphoma Risk
Foo Jn, Smedby Ke, Akers Nk, Berglund M, Irwan Id, Jia Xm, et al
AMERICAN JOURNAL OF HUMAN GENETICS 2013;93(1):167-72

Exposure to UV radiation and risk of Hodgkin lymphoma: a pooled analysis
Monnereau A, Glaser Sl, Schupp Cw, Smedby Ke, De Sanjose S, Kane E, et al
BLOOD 2013;122(20):3492-9

Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia
Berndt Si, Skibola Cf, Joseph V, Camp Nj, Nieters A, Wang Zm, et al
NATURE GENETICS 2013;45(8):868-76

Lifestyle factors, autoimmune disease and family history in prognosis of non-hodgkin lymphoma overall and subtypes
Simard Jf, Baecklund F, Chang Et, Baecklund E, Hjalgrim H, -olov Adami H, et al
International journal of cancer 2013;132(11):2659-66

Low-dose aspirin use and cancer characteristics: a population-based cohort study
Jonsson F, Yin L, Lundholm C, Smedby Ke, Czene K, Pawitan Y
British journal of cancer 2013;109(7):1921-5

Mucosal Healing and Risk for Lymphoproliferative Malignancy in Celiac Disease A Population-Based Cohort Study
Lebwohl B, Granath F, Ekbom A, Smedby Ke, Murray Ja, Neugut Ai, et al
ANNALS OF INTERNAL MEDICINE 2013;159(3):169-75

NOTCH1 and SF3B1 mutations can be added to the hierarchical prognostic classification in chronic lymphocytic leukemia
Mansouri L, Cahill N, Gunnarsson R, Smedby Ke, Tjönnfjord E, Hjalgrim H, et al
Leukemia 2013;27(2):512-4

Overall and cause-specific mortality in transplant recipients with a pretransplantation cancer history
Brattström C, Granath F, Edgren G, Smedby Ke, Wilczek He
Transplantation 2013;96(3):297-305

Patients with ulcerative colitis miss more days of work than the general population, even following colectomy
Neovius M, Arkema Ev, Blomqvist P, Ekbom A, Smedby Ke
Gastroenterology 2013;144(3):536-43

Risk of skin cancer and other malignancies in kidney, liver, heart and lung transplant recipients 1970 to 2008--a Swedish population-based study
Krynitz B, Edgren G, Lindelöf B, Baecklund E, Brattström C, Wilczek H, et al
International journal of cancer 2013;132(6):1429-38

rs2072135, a low-penetrance variant for chronic lymphocytic leukaemia?
Sava Gp, Speedy He, Di Bernardo Mc, Deaglio S, Karabon L, Frydecka I, et al
BRITISH JOURNAL OF HAEMATOLOGY 2013;162(2):221-8

Sex- and Subtype-Specific Analysis of H2AFX Polymorphisms in Non-Hodgkin Lymphoma
Bretherick Kl, Schuetz Jm, Morton Lm, Purdue Mp, Conde L, Gallagher Rp, et al
PLOS ONE 2013;8(9):e74619-

Short telomere length is associated with NOTCH1/SF3B1/TP53 aberrations and poor outcome in newly diagnosed chronic lymphocytic leukemia patients
Mansouri L, Grabowski P, Degerman S, Svenson U, Gunnarsson R, Cahill N, et al
American journal of hematology 2013;88(8):647-51

Smoking, variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma: a pooled analysis within the InterLymph consortium
Gibson Tm, Smedby Ke, Skibola Cf, Hein Dw, Slager Sl, De Sanjose S, et al
CANCER CAUSES & CONTROL 2013;24(1):125-34

["Tools for clinical research"--a new series of articles in Läkartidningen]
Smedby Ke, Lagerros Yt
Lakartidningen 2013;110(3):81-

X chromosome-wide association study of follicular lymphoma
Conde L, Foo Jn, Riby J, Liu Jj, Darabi H, Hjalgrim H, et al
BRITISH JOURNAL OF HAEMATOLOGY 2013;162(6):858-62

A meta-analysis of genome-wide association studies of follicular lymphoma
Skibola Cf, Conde L, Foo Jn, Riby J, Humphreys K, Sille Fcm, et al
BMC GENOMICS 2012;:516-

Genome-Wide Association Study of Classical Hodgkin Lymphoma and Epstein-Barr Virus Status-Defined Subgroups
Urayama Ky, Jarrett Rf, Hjalgrim H, Diepstra A, Kamatani Y, Chabrier A, et al
JOURNAL OF THE NATIONAL CANCER INSTITUTE 2012;104(3):240-53

IGHV3-21 gene frequency in a Swedish cohort of patients with newly diagnosed chronic lymphocytic leukemia
Cahill N, Sutton La, Jansson M, Murray F, Mansouri L, Gunnarsson R, et al
Clinical lymphoma, myeloma & leukemia 2012;12(3):201-6

Importance of RNA isolation methods for analysis of exosomal RNA: Evaluation of different methods
Eldh M, Lotvall J, Malmhall C, Ekstrom K
MOLECULAR IMMUNOLOGY 2012;50(4):278-86

Incidence and time trends of brain metastases admissions among breast cancer patients in Sweden
Frisk G, Svensson T, Bäcklund Lm, Lidbrink E, Blomqvist P, Smedby Ke
British journal of cancer 2012;106(11):1850-3

No association between infections, HLA type and other transplant-related factors and risk of cutaneous squamous cell carcinoma in solid organ transplant recipients
Ingvar Å, Ekström Smedby K, Lindelöf B, Fernberg P, Bellocco R, Tufveson G, et al
Acta dermato-venereologica 2012;92(6):609-14

Self-reported history of infections and the risk of non-Hodgkin lymphoma: An InterLymph pooled analysis
Becker N, Falster Mo, Vajdic Cm, De Sanjose S, Martinez-maza O, Bracci Pm, et al
INTERNATIONAL JOURNAL OF CANCER 2012;131(10):2342-8

Tissue microarray and digital image analysis: a methodological study with special reference to the microenvironment in Hodgkin lymphoma
Glimelius I, Qvarnström F, Simonsson M, Ekwall A, Smedby Ke, Molin D, et al
Histopathology 2012;61(1):26-32

Array-based genomic screening at diagnosis and during follow-up in chronic lymphocytic leukemia
Gunnarsson R, Mansouri L, Isaksson A, Goransson H, Cahill N, Jansson M, et al
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL 2011;96(8):1161-9

Coeliac disease characteristics, compliance to a gluten free diet and risk of lymphoma by subtype
Olen O, Askling J, Ludvigsson Jf, Hildebrand H, Ekbom A, Smedby Ke
DIGESTIVE AND LIVER DISEASE 2011;43(11):862-8

Epidemiology and etiology of mantle cell lymphoma and other non-Hodgkin lymphoma subtypes
Smedby Ke, Hjalgrim H
SEMINARS IN CANCER BIOLOGY 2011;21(5):293-8

GWAS of Follicular Lymphoma Reveals Allelic Heterogeneity at 6p21.32 and Suggests Shared Genetic Susceptibility with Diffuse Large B-cell Lymphoma
Smedby Ke, Foo Jn, Skibola Cf, Darabi H, Conde L, Hjalgrim H, et al
PLOS GENETICS 2011;7(4):e1001378-

LPL is the strongest prognostic factor in a comparative analysis of RNA-based markers in early chronic lymphocytic leukemia
Kaderi Ma, Kanduri M, Buhl Am, Sevov M, Cahill N, Gunnarsson R, et al
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL 2011;96(8):1153-60

Pediatric Organ Transplantation and Risk of Premalignant and Malignant Tumors in Sweden
Simard Jf, Baecklund E, Kinch A, Brattstrom C, Ingvar A, Molin D, et al
AMERICAN JOURNAL OF TRANSPLANTATION 2011;11(1):146-51

Predictors of histology, tissue eosinophilia and mast cell infiltration in Hodgkin's Lymphoma - a population-based study
Glimelius I, Rubin J, Rostgaard K, Amini Rm, Simonsson M, Sorensen Km, et al
EUROPEAN JOURNAL OF HAEMATOLOGY 2011;87(3):208-16

Risk of Lymphoproliferative Malignancy in Relation to Small Intestinal Histopathology Among Patients With Celiac Disease
Elfstrom P, Granath F, Smedby Ke, Montgomery Sm, Askling J, Ekbom A, et al
JOURNAL OF THE NATIONAL CANCER INSTITUTE 2011;103(5):436-44

Time Trends in Risk and Risk Determinants of Non-Hodgkin Lymphoma in Solid Organ Transplant Recipients
Fernberg P, Edgren G, Adami J, Ingvar A, Bellocco R, Tufveson G, et al
AMERICAN JOURNAL OF TRANSPLANTATION 2011;11(11):2472-82

TP53 Mutations are infrequent in newly diagnosed chronic lymphocytic leukemia
Zainuddin N, Murray F, Kanduri M, Gunnarsson R, Smedby Ke, Enblad G, et al
LEUKEMIA RESEARCH 2011;35(2):272-4

Vitamin D Receptor Genotypes, Ultraviolet Radiation Exposure, and Risk of Non-Hodgkin Lymphoma
Smedby Ke, Eloranta S, Duvefelt K, Melbye M, Humphreys K, Hjalgrim H, et al
AMERICAN JOURNAL OF EPIDEMIOLOGY 2011;173(1):48-54

A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3)
Enciso-mora V, Broderick P, Ma Y, Jarrett Rf, Hjalgrim H, Hemminki K, et al
NATURE GENETICS 2010;42(12):1126-1130

ARRAY-BASED GENOMIC PROFILING OF CHRONIC LYMPHOCYTIC LEUKEMIA AT DIAGNOSIS AND FOLLOW-UP
Gunnarsson R, Mansouri M, Isaksson A, Goransson H, Cahill N, Jansson M, et al
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL 2010;:41-41

Birth Order and Risk of Non-Hodgkin Lymphoma-True Association or Bias?
Grulich Ae, Vajdic Cm, Falster Mo, Kane E, Smedby Ke, Bracci Pm, et al
AMERICAN JOURNAL OF EPIDEMIOLOGY 2010;172(6):621-30

Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia risk
Crowther-swanepoel D, Broderick P, Di Bernardo Mc, Dobbins Se, Torres M, Mansouri M, et al
NATURE GENETICS 2010;42(2):132-6

Distinct gene expression profiles in subsets of chronic lymphocytic leukemia expressing stereotyped IGHV4-34 B-cell receptors
Marincevic M, Mansouri M, Kanduri M, Isaksson A, Goransson H, Smedby Ke, et al
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL 2010;95(12):2072-9

Do Rheumatoid Arthritis and Lymphoma Share Risk Factors? A Comparison of Lymphoma and Cancer Risks Before and After Diagnosis of Rheumatoid Arthritis
Hellgren K, Smedby Ke, Feltelius N, Baecklund E, Askling J
ARTHRITIS AND RHEUMATISM 2010;62(5):1252-8

Genetic variation in chromosomal translocation breakpoint and immune function genes and risk of non-Hodgkin lymphoma
Fernberg P, Chang Et, Duvefelt K, Hjalgrim H, Eloranta S, Sorensen Km, et al
CANCER CAUSES & CONTROL 2010;21(5):759-69

Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32
Conde L, Halperin E, Akers Nk, Brown Km, Smedby Ke, Rothman N, et al
NATURE GENETICS 2010;42(8):661-4

HLA-A alleles and infectious mononucleosis suggest a critical role for cytotoxic T-cell response in EBV-related Hodgkin lymphoma
Hjalgrim H, Rostgaard K, Johnson Pcd, Lake A, Shield L, Little Am, et al
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 2010;107(14):6400-5

Immunosuppressive treatment after solid organ transplantation and risk of post-transplant cutaneous squamous cell carcinoma
Ingvar A, Smedby Ke, Lindelof B, Fernberg P, Bellocco R, Tufveson G, et al
NEPHROLOGY DIALYSIS TRANSPLANTATION 2010;25(8):2764-71

Large but not small copy-number alterations correlate to high-risk genomic aberrations and survival in chronic lymphocytic leukemia: a high-resolution genomic screening of newly diagnosed patients
Gunnarsson R, Isaksson A, Mansouri M, Goransson H, Jansson M, Cahill N, et al
LEUKEMIA 2010;24(1):211-5

Pigmentary Characteristics, UV Radiation Exposure, and Risk of Non-Hodgkin Lymphoma: a Prospective Study among Scandinavian Women
Veierod Mb, Smedby Ke, Lund E, Adami Ho, Weiderpass E
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 2010;19(6):1569-76

TP53 MUTATIONS ARE INFREQUENT IN NEWLY-DIAGNOSED CHRONIC LYMPHOCYTIC LEUKEMIA
Murray F, Zainuddin N, Kanduri M, Gunnarsson R, Smedby Ke, Enblad G, et al
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL 2010;:39-39

Verification that common variation at 2q37.1, 6p25.3, 11q24.1, 15q23, and 19q13.32 influences chronic lymphocytic leukaemia risk
Crowther-swanepoel D, Mansouri M, Enjuanes A, Vega A, Smedby Ke, Ruiz-ponte C, et al
BRITISH JOURNAL OF HAEMATOLOGY 2010;150(4):473-9

Atopic Disease and Risk of Non-Hodgkin Lymphoma: An InterLymph Pooled Analysis
Vajdic Cm, Falster Mo, De Sanjose S, Martinez-maza O, Becker N, Bracci Pm, et al
CANCER RESEARCH 2009;69(16):6482-9

Brain metastases admissions in Sweden between 1987 and 2006
Smedby Ke, Brandt L, Backlund Ml, Blomqvist P
BRITISH JOURNAL OF CANCER 2009;101(11):1919-24

Immunoglobulin subclass levels in patients with non-Hodgkin lymphoma
Biggar Rj, Christiansen M, Rostgaard K, Smedby Ke, Adami Ho, Glimelius B, et al
INTERNATIONAL JOURNAL OF CANCER 2009;124(11):2616-20

LARGE BUT NOT SMALL COPY-NUMBER ALTERATIONS CORRELATE TO HIGH-RISK GENOMIC ABERRATIONS AND SURVIVAL IN CHRONIC LYMPHOCYTIC LEUKEMIA: A HIGH-RESOLUTION GENOMIC SCREENING IN NEWLY DIAGNOSED PATIENTS
Gunnarsson R, Isaksson A, Mansouri M, Goransson H, Jansson M, Cahill N, et al
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL 2009;:140-140

LPL Is the Strongest Prognostic Factor in a Comparative Study of RNA-Based Markers in Chronic Lymphocytic Leukemia
Kaderi Ma, Kanduri M, Mansouri M, Buhl Am, Sevov M, Cahill N, et al
BLOOD 2009;114(22):516-516

Risk of EBV-Positive Hodgkin Lymphoma Varies Over 30-Fold by HLA Class I Genotype and History of Infectious Mononucleosis
Jarrett R, Johnson Pcd, Rostgaard K, Lake A, Shield L, Little Am, et al
BLOOD 2009;114(22):114-115

Autoimmune and inflammatory disorders and risk of malignant lymphomas - an update
Smedby Ke, Askling J, Mariette X, Baecklund E
JOURNAL OF INTERNAL MEDICINE 2008;264(6):514-27

Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph consortium
Smedby Ke, Vajdic Cm, Falster M, Engels Ea, Martinez-maza O, Turner J, et al
BLOOD 2008;111(8):4029-38

Borrelia infection and risk of non-Hodgkin lymphoma
Schollkopf C, Melbye M, Munksgaard L, Smedby Ke, Rostgaard K, Glimelius B, et al
BLOOD 2008;111(12):5524-9

Hepatitis C infection and risk of malignant lymphoma
Schollkopf C, Smedby Ke, Hjalgrim H, Rostgaard K, Panum I, Vinner L, et al
INTERNATIONAL JOURNAL OF CANCER 2008;122(8):1885-90

High Resolution Screening of Copy-Number Alterations in Chronic Lymphocytic Leukemia Using Affymetrix 250K SNP-Arrays Reveals a Higher Complexity of Genomic Alterations in Patients with Unmutated IGHV Genes
Gunnarsson R, Isaksson A, Goransson H, Mansouri L, Jansson M, Cahill N, et al
BLOOD 2008;112(11):1074-1074

Non-Hodgkin lymphoma and obesity: A pooled analysis from the InterLymph consortium
Interlymph Consortium, Willett Ev, Morton Lm, Hartge P, Becker N, Bernstein L, et al
INTERNATIONAL JOURNAL OF CANCER 2008;122(9):2062-70

Personal sun exposure and risk of non Hodgkin lymphoma: A pooled analysis from the Interlymph Consortium
Interlymph Consortium, Kricker A, Armstrong Bk, Hughes Am, Goumas C, Smedby Ke, et al
INTERNATIONAL JOURNAL OF CANCER 2008;122(1):144-54

Screening for copy-number alterations and loss of heterozygosity in chronic lymphocytic leukemia - A comparative study of four differently designed, high resolution Microarray platforms
Gunnarsson R, Staaf J, Jansson M, Ottesen Am, Goransson H, Liljedahl U, et al
GENES CHROMOSOMES & CANCER 2008;47(8):697-711

SCREENING FOR COPY-NUMBER ALTERATIONS AND LOSS-OF-HETEROZYGOSITY IN CHRONIC LYMPHOCYTIC LEUKEMIA - A COMPARATIVE STUDY OF FOUR DIFFERENTLY DESIGNED, HIGH RESOLUTION MICROARRAY PLATFORMS
Gunnarsson R, Staaf J, Jansson M, Ottesen Am, Goeransson H, Liljedahl U, et al
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL 2008;:216-216

Serum YKL-40 and Interleukin 6 Levels in Hodgkin Lymphoma
Biggar Rj, Johansen Js, Smedby Ke, Rostgaard K, Chang Et, Adami Ho, et al
CLINICAL CANCER RESEARCH 2008;14(21):6974-8

Allergy and Hodgkin lymphorna - an epidemiological investigation
Scale Project, Hjalgrim H, Ekstrom-smedby K, Rostgaard K
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION 2007;:58-58

Atopy and risk of non-Hodgkin lymphoma
Melbye M, Smedby Ke, Lehtinen T, Rostgaard K, Glimelius B, Munksgaard L, et al
JOURNAL OF THE NATIONAL CANCER INSTITUTE 2007;99(2):158-66

Childhood social environment and risk of non-hodgkin lymphoma in adults
Smedby Ke, Hjalgrim H, Chang Et, Rostgaard K, Glimelius B, Adami Ho, et al
CANCER RESEARCH 2007;67(22):11074-82

Cigarette smoking and risk of Hodgkin lymphoma: A population-based case-control study
Hjalgrim H, Ekstrom-smedby K, Rostgaard K, Amini Rm, Molin D, Hamilton-dutoit S, et al
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 2007;16(8):1561-6

Infectious mononucleosis, childhood social environment, and risk of Hodgkin lymphoma
Hjalgrim H, Smedby Ke, Rostgaard K, Molin D, Hamilton-dutoit S, Chang Et, et al
CANCER RESEARCH 2007;67(5):2382-8

Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype
Smedby Ke, Hjalgrim H, Askling J, T Chang E, Gregersen H, Porwit-macdonald A, et al
JOURNAL OF THE NATIONAL CANCER INSTITUTE 2006;98(1):51-60

Epidemiology and etiology of non-Hodgkin lymphoma - a review
Ekstrom-smedby K
ACTA ONCOLOGICA 2006;45(3):258-71

Malignant lymphomas in autoimmunity and inflammation: A review of risks, risk factors, and lymphoma characteristics
Smedby Ke, Baecklund E, Askling J
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 2006;15(11):2069-77

Nutrient intake and risk of non-Hodgkin's lymphoma
Chang Et, Balter Km, Torrang A, Smedby Ke, Melbye M, Sundstrom C, et al
AMERICAN JOURNAL OF EPIDEMIOLOGY 2006;164(12):1222-32

Reliability of self-reported family history of cancer in a large case-control study of lymphoma
Chang Et, Smedby Ke, Hjalgrim H, Glimelius B, Adami Ho
JOURNAL OF THE NATIONAL CANCER INSTITUTE 2006;98(1):61-8

Variation in DNA repair genes ERCC2, XRCC1, and XRCC3 and risk of follicular lymphoma
Smedby Ke, Lindgren Cm, Hjalgrim H, Humphreys K, Schollkopf C, Chang Et, et al
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 2006;15(2):258-65

Body mass index and risk of malignant lymphoma in Scandinavian men and women
Chang Et, Hjalgrim H, Smedby Ke, Akerman M, Tani E, Johnsen He, et al
JOURNAL OF THE NATIONAL CANCER INSTITUTE 2005;97(3):210-8

Cigarette smoking and risk of non-hodgkin's lymphoma - A population-based case-control study
Schollkopf C, Smedby Ke, Hjalgrim H, Rostgaard K, Gadeberg O, Roos G, et al
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 2005;14(7):1791-6

Dietary factors and risk of non-Hodgkin lymphoma in men and women
Chang Et, Smedby Ke, Zhang Sm, Hjalgrim H, Melbye M, Ost A, et al
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 2005;14(2):512-20

Family history of hematopoietic malignancy and risk of lymphoma
Chang Et, Smedby Ke, Hjalgrim H, Porwit-macdonald A, Roos G, Glimelius B, et al
JOURNAL OF THE NATIONAL CANCER INSTITUTE 2005;97(19):1466-74

Malignant lymphomas in coeliac disease: evidence of increased risks for lymphoma types other than enteropathy-type T cell lymphoma
Smedby Ke, Akerman M, Hildebrand H, Glimelius B, Ekbom A, Askling J
GUT 2005;54(1):54-9

Medication use and risk of non-Hodgkin's lymphoma
Chang Et, Smedby Ke, Hjalgrim H, Schollkopf C, Porwit-macdonald A, Sundstrom C, et al
AMERICAN JOURNAL OF EPIDEMIOLOGY 2005;162(10):965-74

Ultraviolet radiation exposure and risk of malignant lymphomas
Smedby Ke, Hjalgrim H, Melbye M, Torrang A, Rostgaard K, Munksgaard L, et al
JOURNAL OF THE NATIONAL CANCER INSTITUTE 2005;97(3):199-209

Alcohol intake and risk of non-Hodgkin lymphoma in men and women
Chang Et, Smedby Ke, Zhang Sm, Hjalgrim H, Melbye M, Ost A, et al
CANCER CAUSES & CONTROL 2004;15(10):1067-76

Cancer risk following organ transplantation: a nationwide cohort study in Sweden
Adami J, Gabel H, Lindelof B, Ekstrom K, Rydh B, Glimelius B, et al
BRITISH JOURNAL OF CANCER 2003;89(7):1221-7

Risk of malignant lymphomas in patients with rheumatoid arthritis and in their first-degree relatives
Ekstrom K, Hjalgrim H, Brandt L, Baecklund E, Klareskog L, Ekbom A, et al
ARTHRITIS AND RHEUMATISM 2003;48(4):963-70

Cancer incidence in a population-based cohort of individuals hospitalized with Celiac disease or dermatitis herpetiformis
Askling J, Linet M, Gridley G, Halstensen Ts, Ekstrom K, Ekbom A
GASTROENTEROLOGY 2002;123(5):1428-35

Childbearing and the risk of leukemia in Sweden
Ekstrom K, Wuu J, Hsieh Cc, Glimelius B, Lambe M
CANCER CAUSES & CONTROL 2002;13(1):47-53

Single-dose etoposide in advanced pancreatic and biliary cancer, a phase II study
Ekstrom K, Hoffman K, Linne T, Eriksson B, Glimelius B
ONCOLOGY REPORTS 1998;5(4):931-4

Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer
Glimelius B, Ekstrom K, Hoffman K, Graf W, Sjoden Po, Haglund U, et al
ANNALS OF ONCOLOGY 1997;8(2):163-8

A pilot study of factors influencing bowel function after colorectal anastomosis
Graf W, Ekstrom K, Glimelius B, Pahlman L
DISEASES OF THE COLON & RECTUM 1996;39(7):744-9

Visa alla publikationer